Page last updated: 2024-10-23

azelastine and Leishmaniasis, Cutaneous

azelastine has been researched along with Leishmaniasis, Cutaneous in 1 studies

azelastine: azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia
azelastine : A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.

Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Peniche, AG1
Osorio, EY1
Melby, PC1
Travi, BL1

Other Studies

1 other study available for azelastine and Leishmaniasis, Cutaneous

ArticleYear
Efficacy of histamine H1 receptor antagonists azelastine and fexofenadine against cutaneous Leishmania major infection.
    PLoS neglected tropical diseases, 2020, Volume: 14, Issue:8

    Topics: Animals; Histamine H1 Antagonists, Non-Sedating; Leishmania major; Leishmaniasis, Cutaneous; Lymph N

2020